| Low-Dose Valganciclovir Effective in Renal Transplantation - Medscape |
|
|
Medscape Dr. Gabardi: We had been using what some would consider a subtherapeutic dose of 450 mg/day of valganciclovir for 6 months before the drug was approved for prevention of cytomegalovirus in renal transplant recipients. When it was approved for that |